How Fortell is using AI (and $163M) to crack a hearing aid monopoly

The Invisible Monopoly in Your Ears

For decades, the hearing aid market has been a cozy, low-innovation oligopoly. A few massive companies controlled the supply chain, the distribution, and the pricing. The result was a product that worked just well enough to keep customers frustrated, but not well enough to make them want to wear it. People treat glasses like fashion and hearing aids like a medical failure. That is a massive design and engineering gap that has been waiting for someone to exploit it.

Matthew de Jonge noticed something simple: nobody has to be begged to wear their glasses, but almost everyone resists wearing their hearing aids. That realization led to the creation of Fortell. After six years of quiet development and $163 million in funding from heavy hitters like Founders Fund and Thrive Capital, the company is finally showing how AI and modern hardware manufacturing can break a legacy monopoly.

The Engineering Problem Nobody Wanted to Solve

Traditional hearing aids are basically just fancy microphones and speakers that amplify everything. Even the high-end digital ones struggle with what is known as the cocktail party effect—the ability to focus on one voice while filtering out the background noise of a crowded room. Humans do this naturally with their brains. Traditional hardware tries to do it with simple filters. It usually fails.

Fortell isn’t just building a louder speaker. They are building a real-time signal processing engine. By using AI to isolate specific sound signatures and prioritize human speech over environmental static, they are attempting to replicate how a healthy human brain processes sound. This isn’t just a software update; it requires a complete rethink of the silicon inside the device. If you want to solve this at the edge, you can't rely on a cloud connection with high latency. It has to happen locally, in real-time, in a form factor smaller than a grape.

Six Years of R&D is the New Standard

In the world of SaaS, we are used to the 'move fast and break things' mantra. You launch a crappy MVP, get some feedback, and iterate. But in hardware—specifically medical-adjacent hardware—that approach doesn't work. De Jonge spent six years in the trenches before this became a headline. That is a lifetime in the tech world, but it’s the price of entry if you want to disrupt a sector protected by complex regulations and deep-pocketed incumbents.

For builders, the lesson here is about patience and capital efficiency. Raising $163 million sounds like a lot, but when you are fighting a monopoly that has owned the market for fifty years, you need a war chest. You have to fund the R&D, the clinical testing, and eventually, the massive marketing push required to change consumer behavior. Fortell isn't just selling a gadget; they are trying to rebrand a category.

Why AI Matters Here (And Why It Isn’t Hype)

We see a lot of AI 'wrappers' these days—startups that just put a pretty interface on top of an existing LLM. Fortell is the opposite. This is a practical application of machine learning where the AI is the core utility. The model has to distinguish between a clinking glass, a humming air conditioner, and your spouse’s voice. It has to do this thousands of times per second.

This is where the 'builder-first' perspective gets interesting. The real value isn't in the fact that it uses AI; it's in the specific dataset and the proprietary processing logic they've built. By focusing on the acoustic environment, they are creating a defensive moat that a generic tech company can't easily cross. They aren't just using AI to write emails; they are using it to fix a fundamental sensory limitation.

The Stigma Gap

Why do we love Warby Parker but dread the audiologist? It comes down to friction and aesthetics. The legacy hearing aid companies designed products for clinicians, not for the people wearing them. They were designed to be hidden, which paradoxically made them more noticeable because they looked like medical prosthetics.

Fortell is betting that if they make the technology superior and the design palatable, they can shift the perception of hearing assistance from a sign of aging to a piece of performance tech. It’s the 'Oura Ring' strategy applied to hearing. If you make it cool and functional, people will pay a premium for it. More importantly, they will actually use it.

The Monopoly's Weakness

Monopolies get lazy. They stop innovating because they own the distribution channels. The hearing aid giants relied on the fact that you had to go through a specific doctor to get their product. But regulations are changing, and the consumer's willingness to go direct-to-manufacturer is increasing. Fortell is entering the market at a moment when the gatekeepers are losing their grip.

When a monopoly stops listening to the end user, they leave a door open. De Jonge and his team spent six years walking through that door. They realized that the 'begging' problem wasn't a character flaw in the elderly; it was a design flaw in the product. If the product was actually good, you wouldn't have to convince anyone to use it.

What This Means for the Next Wave of Founders

If you are looking for the next big opportunity, don't look at the crowded markets where everyone is building the same AI chat bot. Look at the boring, dusty industries where the leaders haven't changed in forty years. Look for the products that people use out of necessity but hate with a passion.

Success in these areas requires a different kind of founder. You need the technical depth to understand the signal processing, the grit to survive a half-decade of development, and the vision to see a medical device as a consumer product. It is a high-stakes, high-reward path that most founders are too afraid to take.

Final Takeaway

Fortell is a reminder that the most significant technology isn't always the one that generates the most tweets. It’s the technology that fixes a broken human experience. By combining a massive capital raise with a long-term R&D cycle, they are positioned to turn a medical necessity into a piece of high-end consumer electronics. The legacy players should be very, very worried.

Read the original at TechCrunch Startups →